Harmonising and competing for medicines regulation: how healthy are the European Union's systems of drug approval?
- 14 May 1999
- journal article
- Published by Elsevier in Social Science & Medicine
- Vol. 48 (11) , 1655-1667
- https://doi.org/10.1016/s0277-9536(99)00042-8
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Who Needs Faster Drug Approval Times in Canada: The Public or the Industry?International Journal of Health Services, 1994
- The Drug Lag Issue: The Debate Seen from an International PerspectiveInternational Journal of Health Services, 1992
- Drug makers and drug regulators: Too close for comfort. A study of the Canadian situationSocial Science & Medicine, 1990
- Differing attitudes of industry and academia towards controlled clinical trialsEuropean Journal of Clinical Investigation, 1986